HSA — authorised 6 April 2011
- Marketing authorisation holder: IPR PHARMS INC
- Status: likely_approved
🇸🇬 Caprelsa in Singapore
HSA authorised Caprelsa on 6 April 2011
Marketing authorisation
Caprelsa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Caprelsa approved in Singapore?
Yes. HSA authorised it on 6 April 2011.
Who is the marketing authorisation holder for Caprelsa in Singapore?
IPR PHARMS INC holds the Singaporean marketing authorisation.